Curbing Breast Cancer by Altering V-ATPase Action on F-Actin, Heterochromatin, ETV7 and mTORC2 Signaling
dc.creator | Khan, Zeina S. (TTU) | |
dc.creator | Hussain, Fazle (TTU) | |
dc.date.accessioned | 2024-07-29T16:07:08Z | |
dc.date.available | 2024-07-29T16:07:08Z | |
dc.date.issued | 2024 | |
dc.description | © 2024 The Author(s). cc-by | |
dc.description.abstract | Background/Aims: Motivated by the vacuolar proton pump’s importance in cancer, we investigate the effects of proton pump inhibition on breast cancer cell migration and proliferation, F-actin polymerization, lamin A/C, heterochromatin, and ETV7 expressions, nuclear size and shape, and AKT/mTOR signaling. Methods: Lowly metastatic MCF7 and highly metastatic MDA-MB-231 breast cancer cells were treated with 120 nM of proton pump inhibitor Bafilomycin A1 for 24 hours. Cell migration was studied with wound- scratch assays, ATP levels with a chemiluminescent assay; cell proliferation was quantified by a cell area expansion assay. Nuclear size and shape were determined using DAPI nuclear stain and fluorescence microscopy. The levels of F-actin, lamin A/C, heterochromatin, and ETV7 were quantified using both immunocytochemistry and western blots; p-mTORC1, p-mTORC2, mTOR, p-AKT, and AKT were measured by western blots. Results: We reveal that proton pump inhibition reduces F-actin polymerization, cell migration, proliferation, and increases heterochromatin in both lowly and highly metastatic cells. Surprisingly, Bafilomycin decreases lamin A/C in both cell lines. Inhibition has different effects on ETV7 expression in lowly and highly metastatic cells, as well as nuclear area, perimeter, and circularity. Bafilomycin also significantly decreases p-mTORC1, p-MTORC2, and MTOR expression in both cell lines, whereas it significantly decreases p-AKT in lowly metastatic cells and surprisingly significantly increases p-AKT in highly metastatic cells. Our proton pump inhibition protocol reduces V-ATPase levels (~25%) within three hours. V-ATPase levels vary in time for both control and inhibited cells, and inhibition reduces cellular ATP. Conclusions: Proton pumps promote F-actin polymerization and decrease heterochromatin, facilitating invasion. These pumps also upregulate both mTORC1 and mTORC2, thus highlighting the relevance of vacuolar proton pumps as metastatic cancer targets. | |
dc.identifier.citation | Khan, Z.S., & Hussain, F.. 2024. Curbing Breast Cancer by Altering V-ATPase Action on F-Actin, Heterochromatin, ETV7 and mTORC2 Signaling. Cellular Physiology and Biochemistry, 58(3). https://doi.org/10.33594/000000706 | |
dc.identifier.uri | https://doi.org/10.33594/000000706 | |
dc.identifier.uri | https://hdl.handle.net/2346/99230 | |
dc.language.iso | eng | |
dc.subject | AKT | |
dc.subject | ETV7 | |
dc.subject | Lamin A/C | |
dc.subject | mTOR | |
dc.subject | V-ATPase | |
dc.title | Curbing Breast Cancer by Altering V-ATPase Action on F-Actin, Heterochromatin, ETV7 and mTORC2 Signaling | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- khan_article.pdf
- Size:
- 5.24 MB
- Format:
- Adobe Portable Document Format
- Description:
- Main article with TTU Libraries cover page